What labs should a TRT clinic order?

Why baseline labs matter

A single testosterone measurement taken at any time of day is not sufficient to diagnose hypogonadism. Testosterone levels fluctuate naturally, and most clinical guidelines recommend confirmation with at least two early-morning blood draws on separate days. The Endocrine Society guideline also asks for a fasting sample, since eating can lower the reading. Beyond confirming low testosterone, baseline labs serve another purpose: ruling out other conditions that can cause similar symptoms, such as thyroid dysfunction, elevated prolactin, or sleep-related issues. A provider who prescribes without this context is missing important information.

Baseline labs also establish your reference points. These are the values your provider will compare against as your treatment progresses. Without a clear baseline, it is harder to interpret changes during treatment.

• Ask whether the clinic draws testosterone on two separate mornings to confirm low levels.
• Ask what other markers are included in the baseline panel beyond testosterone.
• Find out whether a provider reviews your results and discusses findings with you before prescribing.

Common markers in a TRT baseline panel

While individual providers and clinical guidelines vary, a thorough baseline panel for TRT evaluation commonly includes: total testosterone, free testosterone, sex hormone binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, complete blood count (CBC), and a metabolic panel. PSA (prostate-specific antigen) is typically included for men over a certain age or with relevant risk factors. Some providers also include thyroid function tests and prolactin.

The purpose of these tests varies. LH and FSH help determine whether low testosterone originates in the testes or the pituitary, a distinction that affects treatment approach. Estradiol is monitored because testosterone can convert to estrogen in the body. CBC provides a baseline for hematocrit, which requires monitoring during treatment. The metabolic panel assesses liver and kidney function, which can be affected by hormone therapy.

If LH and FSH are low or normal alongside low testosterone (secondary hypogonadism), the Endocrine Society guideline suggests looking for an underlying cause before treating, starting with tests such as prolactin and iron saturation. Ask whether the clinic follows up on that pattern or prescribes without checking.

• Total and free testosterone: confirms diagnosis and provides a treatment baseline.
• LH and FSH: helps distinguish primary from secondary hypogonadism.
• Estradiol: establishes a baseline for estrogen monitoring during treatment.
• CBC (hematocrit/hemoglobin): baseline before treatment that will be monitored for elevation.
• PSA: relevant for prostate safety assessment, especially for older patients.
• Metabolic panel: assesses liver, kidney, and metabolic baseline.

What ongoing monitoring should include

Once treatment begins, monitoring labs are typically ordered at follow-up intervals defined by your provider's protocol. These panels assess whether your testosterone levels are within the target range for your treatment, whether estradiol is elevated, and whether your hematocrit is increasing. That is a common effect of testosterone therapy that requires attention. The frequency of monitoring varies by provider and by how your body responds to treatment.

The Endocrine Society guideline gives a useful benchmark for comparing clinic protocols: recheck testosterone 3 to 6 months after starting; check hematocrit before treatment, again at 3 to 6 months, and then yearly; and stop therapy until it comes down if hematocrit rises above 54%. For men who have chosen prostate monitoring, it suggests checking PSA before treatment and again 3 to 12 months after starting, then following standard screening guidance. Clinics may check more often than this, which is not a problem; checking less often is worth asking about.

Ask your provider specifically which markers are checked at each follow-up and whether the panel changes over time as your treatment stabilizes. A clinic that can give you a clear, specific answer to this question is one that has a coherent monitoring protocol.

• Testosterone (total and/or free): assesses whether you are in the therapeutic range.
• Hematocrit/hemoglobin: monitors for elevation that may require a dosage adjustment.
• Estradiol: monitors for conversion of testosterone to estrogen.
• PSA: periodic monitoring for prostate safety, particularly for older patients.

Red flags in a clinic's lab approach

Some red flags in a clinic's lab approach are worth knowing before you sign up. Clinics that offer a prescription after a single questionnaire without any lab work are cutting a corner that could affect your safety. Clinics that draw labs but do not have a licensed provider review results before prescribing are another concern. And clinics that do not have a clear, specific answer about their ongoing monitoring protocol are unlikely to manage your care responsibly over time.

A related red flag is a clinic that discourages or does not accommodate your bringing outside lab results. If you have recent labs from your primary care physician that your TRT provider will not review, that limits the quality of your care.

• Prescribing without any prior lab work is a significant red flag.
• Labs ordered but not reviewed by a licensed provider before prescribing is a concern.
• No clear monitoring protocol after treatment begins is a warning sign.
• Unwillingness to review outside labs limits care quality.

Using lab knowledge to evaluate providers

You do not need to be a clinician to use this information constructively. Before you book a consultation, ask the clinic what their baseline panel includes and what their monitoring schedule looks like. A responsible provider will give you a clear, specific answer. One that deflects, gives vague answers, or frames lab work as optional is telling you something important about how they operate.

Use a directory like TRTIndex to browse providers and compare what they make publicly available about their diagnostic process. Then follow up directly with specific questions before committing to any program.

To see what these panels typically cost, read TRT lab costs. For online providers that include labs in their monthly price, see the TRT Cost Index.

Sources

• Bhasin S, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744.
• Mulhall JP, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432.

Medical disclaimer: This guide is for general information only and is not medical advice, diagnosis, or treatment. TRT decisions should be made with a licensed clinician who can review your symptoms, labs, medical history, risks, and goals.